We just received data on a new analyst forecast for $FEMY. Yale Jen from Laidlaw & Co. set a price target of 6.5 for FEMY.
To track analyst ratings and price targets for $FEMY, check out Quiver Quantitative's $FEMY forecast page.
Should you buy $FEMY?
Some analysts are better than others. To view the past performance of Laidlaw & Co., check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$FEMY Price Targets
Multiple analysts have issued price targets for $FEMY recently. We have seen 2 analysts offer price targets for $FEMY in the last 6 months, with a median target of $7.25.
Here are some recent targets:
- Yale Jen from Laidlaw & Co. set a target price of $6.5 on 11/20/2025
- Emily Bodnar from HC Wainwright & Co. set a target price of $8.0 on 08/11/2025
$FEMY Hedge Fund Activity
We have seen 12 institutional investors add shares of $FEMY stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DAUNTLESS INVESTMENT GROUP, LLC removed 588,235 shares (-25.3%) from their portfolio in Q3 2025, for an estimated $207,294
- CM MANAGEMENT, LLC removed 225,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,290
- ROYAL BANK OF CANADA removed 163,034 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $57,453
- CLEAR CREEK FINANCIAL MANAGEMENT, LLC removed 142,918 shares (-50.7%) from their portfolio in Q3 2025, for an estimated $50,364
- CITADEL ADVISORS LLC removed 106,298 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $37,459
- UBS GROUP AG removed 104,416 shares (-85.4%) from their portfolio in Q3 2025, for an estimated $36,796
- JANE STREET GROUP, LLC removed 84,459 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $29,763
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
